Article

Chronic Autoimmune Neurological Disorders and Immunosuppression During the COVID-19 Pandemic

2020-09-18

Abstract excerpt

Background: The corona virus disease 2019 (COVID-19) pandemic has led to uncertainty regarding the best management practice for patients with chronic autoimmune neurological disorders (cANDs) who require immunosuppressive therapies (ISTs). While ISTs are often essential to control cANDs, there is concern that ISTs may make this patient population more susceptible to COVID-19 and related complications. Expert opi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1c3b90ec-dcdd-597c-b91c-1c2e399b6efa
DOI: 10.2139/ssrn.3633220

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Chronic Autoimmune Neurological Disorders and Immunosuppression During the COVID-19 PandemicDOI 10.2139/ssrn.3633220Read

Disease Modifying Therapies and COVID-19 Severity in Multiple SclerosisSemantic proximity Read

RISK FACTORS FOR INFECTION AND HEALTH IMPACTS OF THE COVID-19 PANDEMIC IN PEOPLE WITH AUTOIMMUNE DISEASESSemantic proximity Read

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.Semantic proximity Read

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendationsSemantic proximity Read

The Impact of COVID-19 Vaccination on Autoimmune Disorders: A Descriptive AnalysisSemantic proximity Read

Study Protocol for DeCOmPRESS: Defining the Disease Course and Immune Profile of COVID-19 in the Immunosuppressed PatientSemantic proximity Read

COVID-19 vaccines and autoimmune disorders: A scoping review protocolSemantic proximity Read

The risks of autoimmune- and inflammatory post-acute COVID-19 conditions: a network cohort study in six European countries, the US, and KoreaSemantic proximity Read

COVID-19–Associated Macrophage Activation Syndrome: Clinical Characteristics, Treatment Patterns, and Outcomes from a Hospitalized CohortSemantic proximity Read

Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort StudySemantic proximity Read

COVID-19 OUTCOMES IN MS: EARLY EXPERIENCE FROM NYU MULTIPLE SCLEROSIS COMPREHENSIVE CARE CENTERSemantic proximity Read

A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic DiseasesSemantic proximity Read